arrow
R

Robin Park

The Scripps Research Institute
H指数:21
被引数:1,399

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

S2303: phase II/III trial of paclitaxel plus ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

S2303: 紫杉醇联合雷莫芦单抗 ± nivolumab治疗胃和食管腺癌 (PARAMUNE) 的II/III期试验

2025-03-010
OAAI
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort
2024-02-2010
OAAI
PHASE I/II TRIAL OF CABOZANTINIB PLUS DURVALUMAB IN ADVANCED GASTROESOPHAGEAL CANCER AND OTHER GASTROINTESTINAL MALIGNANCIES (CAMILLA): PHASE IB SAFETY AND EFFICACY RESULTS
2021-11-102
OA